Table 3.
Adjusted group means of INC scores of the pooled dataset
| RSN | HC | S-MT | S-L | S-D | S-MA | S-MT versus HC | S-L versus HC | S-D versus HC | S-MA versus HC | S-MT versus S-L | S-MT versus S-D | S-MT versus S-MA | S-L versus S-D | S-L versusS-MA | S-D versus S-MA | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean (SE) | P (overall) | P FDR corrected | P post hoc comparisons | ||||||||||||||
| DMN | −0.01 (0.11) | −0.18 (0.14) | 0.38 (0.16) | −0.27 (0.12) | −0.12 (0.15) | 0.02* | 0.035* | 0.36 | 0.054 | 0.11 | 0.57 | 0.01* | 0.58 | 0.78 | <0.001* | 0.02* | 0.40 |
| DAN | 0.01 (0.12) | −0.58 (0.15) | −0.37 (0.17) | −0.58 (0.12)† | −0.42 (0.16) | 0.01* | 0.035* | 0.003* | 0.07 | 0.001* | 0.04* | 0.36 | 1.00 | 0.48 | 0.32 | 0.83 | 0.43 |
| CON | −0.06 (0.12) | −0.24 (0.15) | 0.25 (0.17) | −0.16 (0.12) | −0.09 (0.16) | 0.24 | 0.28 | 0.33 | 0.15 | 0.55 | 0.88 | N.a. | N.a. | N.a. | N.a. | N.a. | N.a. |
| SAL | −0.02 (0.14) | 0.12 (0.18) | 0.53 (0.20) | 0.13 (0.15) | 0.47 (0.19) | 0.13 | 0.18 | 0.57 | 0.03* | 0.51 | 0.05 | N.a. | N.a. | N.a. | N.a. | N.a. | N.a. |
| LN | −0.04 (0.10) | −0.10 (0.13) | 0.07 (0.15) | −0.32 (0.11) | −0.52 (0.14)† | 0.02* | 0.035* | 0.76 | 0.53 | 0.08 | 0.01* | 0.4 | 0.18* | 0.03* | 0.03 | 0.01* | 0.25 |
| VN | 0.02 (0.12) | −0.74 (0.14) | −0.14 (0.16) | −0.55 (0.12) | −0.32 (0.15) | <0.001* | 0.007* | <0.001* | 0.41 | 0.001* | 0.08 | 0.01* | 0.30 | 0.05 | 0.04* | 0.42 | 0.24 |
| SMN | −0.06 (0.10) | −0.02 (0.13) | −0.03 (0.15) | 0.04 (0.11) | −0.13 (0.14) | 0.89 | 0.89 | 0.78 | 0.84 | 0.49 | 0.72 | N.a. | N.a. | N.a. | N.a. | N.a. | N.a. |
Notes: *Two-tailed P < 0.05.
†P < 0.05 in analysis of covariance -with adjustments for age, sex, APOE genotype and years of education—between any atrophy subgroup DELCODE versus ADNI.